Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-05-21 Sale |
2021-05-25 8:00 pm |
ImmunityBio Inc. | IBRX | Simon Barry J. Director |
125,000 | $16.14 | $2,018,057 | 3,102,507 (Direct) |
View |
| 2021-02-05 Sale |
2021-02-08 4:54 pm |
NantKwest Inc. | NK | Simon Barry J. See remarks |
22,100 | $23.09 | $510,267 | 3,280,560 (Direct) |
View |
| 2021-02-02 Sale |
2021-02-04 6:39 pm |
NantKwest Inc. | NK | Simon Barry J. See remarks |
82,070 | $20.65 | $1,694,803 | 3,302,660 (Direct) |
View |
| 2021-01-27 Sale |
2021-01-29 7:59 pm |
NantKwest Inc. | NK | Simon Barry J. See remarks |
47,930 | $20.59 | $987,067 | 3,610,224 (Direct) |
View |
| 2020-12-22 Sale |
2020-12-28 6:23 pm |
NantKwest Inc. | NK | Simon Barry J. See remarks |
130,000 | $18.05 | $2,346,604 | 3,432,660 (Direct) |
View |
| 2020-07-20 Sale |
2020-07-22 4:05 pm |
NantKwest Inc. | NK | Simon Barry J. See remarks |
130,000 | $15.53 | $2,019,329 | 4,013,312 (Direct) |
View |
| 2020-07-08 Sale |
2020-07-10 5:00 pm |
NantKwest Inc. | NK | Simon Barry J. See remarks |
39,950 | $13.14 | $524,759 | 3,268,237 (Direct) |
View |
| 2020-06-30 Sale |
2020-07-02 6:32 pm |
NantKwest Inc. | NK | Simon Barry J. See remarks |
9 | $13 | $117 | 3,308,187 (Direct) |
View |
| 2020-06-19 Sale |
2020-06-23 9:45 pm |
NantKwest Inc. | NK | Simon Barry J. See remarks |
200,041 | $10.56 | $2,112,950 | 3,779,455 (Direct) |
View |
| 2020-05-27 Sale |
2020-05-29 4:27 pm |
NantKwest Inc. | NK | Simon Barry J. See remarks |
75,000 | $7.5645 | $567,338 | 3,194,906 (Direct) |
View |
| 2020-05-21 Sale |
2020-05-22 5:37 pm |
NantKwest Inc. | NK | Simon Barry J. See remarks |
36,932 | $5.5155 | $203,698 | 3,269,906 (Direct) |
View |
| 2020-05-11 Sale |
2020-05-13 8:04 pm |
NantKwest Inc. | NK | Simon Barry J. See remarks |
28,068 | $5.5048 | $154,509 | 3,306,838 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-22 Tax Withholding |
2025-02-25 9:11 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Simon Barry J. Director |
5,453 | $3.42 | 3,274,059 (Direct) |
View |
| 2025-02-22 Exercise |
2025-02-25 9:11 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Simon Barry J. Director |
15,243 | $0 | 3,274,059 (Direct) |
View |
| 2025-01-22 Exercise |
2025-01-24 8:47 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Simon Barry J. Director |
110,020 | $1.9984 | 3,233,781 (Direct) |
View |
| 2025-01-22 Exercise |
2025-01-24 8:47 pm |
N/A 2025-02-16 |
ImmunityBio Inc. | IBRX | Simon Barry J. Director |
110,020 | $0 | 3,233,781 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-24 7:44 pm |
N/A 2034-06-20 |
Viracta Therapeutics Inc. | VIRX | Simon Barry J. Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 4:43 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Simon Barry J. Director |
204,877 | $0 | 204,877 (Direct) |
View |
| 2024-01-31 Tax Withholding |
2024-02-02 7:38 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Simon Barry J. Director |
22,094 | $3.36 | 3,123,761 (Direct) |
View |
| 2024-01-31 Exercise |
2024-02-02 7:38 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Simon Barry J. Director |
57,200 | $0 | 3,123,761 (Direct) |
View |
| 2023-09-01 Exercise |
2023-09-06 7:39 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Simon Barry J. Director |
57,199 | $0 | 3,145,855 (Direct) |
View |
| 2023-08-25 Option Award |
2023-08-28 9:01 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Simon Barry J. Director |
114,399 | $0 | 114,399 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-09 6:49 pm |
N/A 2033-06-08 |
Viracta Therapeutics Inc. | VIRX | Simon Barry J. Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:16 pm |
N/A 2032-06-09 |
Viracta Therapeutics Inc. | VIRX | Simon Barry J. Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-03-23 Option Award |
2022-03-25 9:05 pm |
N/A 2032-03-23 |
ImmunityBio Inc. | IBRX | Simon Barry J. Director |
10,714 | $0 | 10,714 (Direct) |
View |
| 2021-06-04 Ownership |
2022-01-28 4:28 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Simon Barry J. Director |
71,051 | $0 | 3,031,456 (Direct) |
View |
| 2021-05-05 Exercise |
2021-05-07 4:09 pm |
N/A 2024-12-18 |
ImmunityBio Inc. | IBRX | Simon Barry J. Director |
56,967 | $0 | 3,227,507 (Direct) |
View |
| 2021-05-05 Exercise |
2021-05-07 4:09 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Simon Barry J. Director |
56,967 | $1.7544 | 3,227,507 (Direct) |
View |
| 2021-03-26 Option Award |
2021-03-30 8:21 pm |
N/A 2031-03-26 |
Viracta Therapeutics Inc. | VIRX | Simon Barry J. Director |
80,000 | $0 | 80,000 (Direct) |
View |
Ownership |
2021-03-04 5:46 pm |
N/A 2028-12-15 |
Viracta Therapeutics Inc. | VIRX | Simon Barry J. Director |
0 | $0 | 11,190 (Direct) |
View |
| 2021-02-05 Exercise |
2021-02-08 4:54 pm |
N/A N/A |
NantKwest Inc. | NK | Simon Barry J. See remarks |
22,100 | $1.9984 | 3,280,560 (Direct) |
View |
| 2021-02-05 Exercise |
2021-02-08 4:54 pm |
N/A 2025-02-16 |
NantKwest Inc. | NK | Simon Barry J. See remarks |
22,100 | $0 | 3,280,560 (Direct) |
View |
| 2021-02-02 Exercise |
2021-02-04 6:39 pm |
N/A N/A |
NantKwest Inc. | NK | Simon Barry J. See remarks |
82,070 | $1.9984 | 3,302,660 (Direct) |
View |
| 2021-02-02 Exercise |
2021-02-04 6:39 pm |
N/A 2025-02-16 |
NantKwest Inc. | NK | Simon Barry J. See remarks |
82,070 | $0 | 3,302,660 (Direct) |
View |
| 2021-01-27 Exercise |
2021-01-29 7:59 pm |
N/A N/A |
NantKwest Inc. | NK | Simon Barry J. See remarks |
47,930 | $1.9984 | 3,610,224 (Direct) |
View |
| 2021-01-27 Exercise |
2021-01-29 7:59 pm |
N/A 2025-02-16 |
NantKwest Inc. | NK | Simon Barry J. See remarks |
47,930 | $0 | 3,610,224 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 4:46 pm |
N/A 2031-01-03 |
Cue Biopharma Inc. | CUE | Simon Barry J. Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2020-12-22 Exercise |
2020-12-28 6:23 pm |
N/A N/A |
NantKwest Inc. | NK | Simon Barry J. See remarks |
130,000 | $1.9984 | 3,432,660 (Direct) |
View |
| 2020-12-22 Exercise |
2020-12-28 6:23 pm |
N/A 2025-02-16 |
NantKwest Inc. | NK | Simon Barry J. See remarks |
130,000 | $0 | 3,432,660 (Direct) |
View |
| 2020-07-20 Exercise |
2020-07-22 4:05 pm |
N/A N/A |
NantKwest Inc. | NK | Simon Barry J. See remarks |
89,270 | $1.9984 | 4,013,312 (Direct) |
View |
| 2020-07-20 Exercise |
2020-07-22 4:05 pm |
N/A 2024-12-18 |
NantKwest Inc. | NK | Simon Barry J. See remarks |
130,000 | $0 | 4,013,312 (Direct) |
View |
| 2020-07-20 Exercise |
2020-07-22 4:05 pm |
N/A N/A |
NantKwest Inc. | NK | Simon Barry J. See remarks |
40,730 | $1.7554 | 4,013,312 (Direct) |
View |
| 2020-07-08 Exercise |
2020-07-10 5:00 pm |
N/A 2024-12-18 |
NantKwest Inc. | NK | Simon Barry J. See remarks |
39,950 | $0 | 3,268,237 (Direct) |
View |
| 2020-07-08 Exercise |
2020-07-10 5:00 pm |
N/A N/A |
NantKwest Inc. | NK | Simon Barry J. See remarks |
39,950 | $1.7554 | 3,268,237 (Direct) |
View |
| 2020-06-30 Exercise |
2020-07-02 6:32 pm |
N/A 2024-12-18 |
NantKwest Inc. | NK | Simon Barry J. See remarks |
9 | $0 | 3,308,187 (Direct) |
View |
| 2020-06-30 Exercise |
2020-07-02 6:32 pm |
N/A N/A |
NantKwest Inc. | NK | Simon Barry J. See remarks |
9 | $1.7554 | 3,308,187 (Direct) |
View |
| 2020-06-19 Exercise |
2020-06-23 9:45 pm |
N/A 2024-12-18 |
NantKwest Inc. | NK | Simon Barry J. See remarks |
175,675 | $0 | 3,779,455 (Direct) |
View |
| 2020-06-19 Exercise |
2020-06-23 9:45 pm |
N/A N/A |
NantKwest Inc. | NK | Simon Barry J. See remarks |
175,675 | $1.7554 | 3,779,455 (Direct) |
View |